SCHEMBL14049180

SCHEMBL14049180

Cc1c(Cc2cccc(C3O[C@H](CO)[C@@H](O)C(O)[C@H]3O)c2)sc2ccccc12

nearest known ligand 0.64

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ SLC5A2 P31639 20/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12426004 1.00 SLC5A2 (0.64) SLC5A2
SCHEMBL12426005 0.89 SLC5A2 (0.59) SLC5A2
SCHEMBL14049176 0.88 SLC5A2 (0.58) SLC5A2
SCHEMBL12426008 0.88 SLC5A2 (0.58) SLC5A2
SCHEMBL12426012 0.79 SLC5A2 (0.65) SLC5A2
SCHEMBL14049015 0.79 SLC5A2 (0.65) SLC5A2
SCHEMBL9973926 0.78 SLC5A2 (1.00) SLC5A2
SCHEMBL220972 0.78 SLC5A2 (1.00) SLC5A2
SCHEMBL147718 0.78 SLC5A2 (1.00) SLC5A2
SCHEMBL12662714 0.78 SLC5A2 (1.00) SLC5A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1980560-A2 C-glycoside derivatives for the treatment of diabetes Astellas Pharma Inc. (JP) 2008-10-15 — — EP disclosed
Send feedback